CLINICAL STUDIES
Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study
J. Anthony Gomes, MD, FACCa,
John Ip, MD, FACC*,
Francesco Santoni-Rugiu, MDa,
Davendra Mehta, MD, PhD, FACCa,
Arisan Ergin, MDa,
Steven Lansman, MDa,
Elena Pe, RN, NPa,
Teri Takle Newhouse, MS and
Sally Chao, BSa
a Electrophysiology and Electrocardiography Section, the Zena and Michael Wiener Cardiovascular Institute, Department of Medicine, The Mount Sinai School of Medicine and the Mount Sinai Medical Center, New York, New York, USA
* Thoracic Cardiovascular Institute, Lansing, Michigan, USA
Biostatistics Department, Medronic, Minneapolis, Minnesota, USA
Manuscript received July 14, 1998;
revised manuscript received March 25, 1999,
accepted April 21, 1999.
Reprint requests and correspondence: Dr. J. Anthony Gomes, Box 1054, The Mount Sinai Medical Center, 1 Gustave L. Levy Place, New York, New York 10029
OBJECTIVES
The purpose of this prospective, randomized, double-blind, placebo-controlled study was to assess the efficacy of preoperatively and postoperatively administered oral d,l sotalol in preventing the occurrence of postoperative atrial fibrillation (AF).
BACKGROUND
Atrial fibrillation is the most common arrhythmia following coronary artery bypass surgery (CABG). Its etiology, prevention and treatment remain highly controversial. Furthermore, its associated morbidity results in a prolongation of the length of hospital stay post-CABG.
METHODS
A total of 85 patients, of which 73 were to undergo CABG and 12 CABG plus valvular surgery (ejection fraction 28% and absence of clinical heart failure), were randomized to receive either sotalol (40 patients; mean dose = 190 ± 43 mg/day) started 24 to 48 h before open heart surgery and continued for four days postoperatively, or placebo (45 patients, mean dose = 176 ± 32 mg/day).
RESULTS
Atrial fibrillation occurred in a total of 22/85 (26%) patients. The incidence of postoperative AF was significantly (p = 0.008) lower in patients on sotalol (12.5%) as compared with placebo (38%). Significant bradycardia/hypotension, necessitating drug withdrawal, occurred in 2 of 40 (5%) patients on sotalol and none in the placebo group (p = 0.2). None of the patients on sotalol developed Torsade de pointes or sustained ventricular arrhythmias. Postoperative mortality was not significantly different in sotalol versus placebo (0% vs. 2%, p = 1.0). Patients in the sotalol group had a nonsignificantly shorter length of hospital stay as compared with placebo (7 ± 2 days vs. 8 ± 4 days; p = 0.24).
CONCLUSIONS
The administration of sotalol, in dosages ranging from 80 to 120 mg, was associated with a significant decrease (67%) in postoperative AF in patients undergoing CABG without appreciable side effects. Sotalol should be considered for the prevention of postoperative AF in patients undergoing CABG in the absence of heart failure and significant left ventricular dysfunction.
|
Abbreviations and Acronyms
| | AF | = atrial fibrillation | | AV | = atrioventricular | | CABG | = coronary artery bypass surgery | | LVEF | = left ventricular ejection fraction |
|
This article has been cited by other articles:

|
 |

|
 |
 
L. Iliuta, R. Christodorescu, D. Filpescu, H. Moldovan, B. Radulescu, and R. Vasile
Prevention of perioperative atrial fibrillation with betablockers in coronary surgery: betaxolol versus metoprolol
Interactive CardioVascular and Thoracic Surgery,
July 1, 2009;
9(1):
89 - 93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Shrivastava, B. Smith, D. Caskey, and P. Reddy
Atrial Fibrillation After Cardiac Surgery: Does Prophylactic Therapy Decrease Adverse Outcomes Associated With Atrial Fibrillation
J Intensive Care Med,
January 1, 2009;
24(1):
18 - 25.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Cavolli, K. Kaya, A. Aslan, O. Emiroglu, S. Erturk, O. Korkmaz, M. Oguz, R. Tasoz, and U. Ozyurda
Does Sodium Nitroprusside Decrease the Incidence of Atrial Fibrillation After Myocardial Revascularization?: A Pilot Study
Circulation,
July 29, 2008;
118(5):
476 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Echahidi, P. Pibarot, G. O'Hara, and P. Mathieu
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
J. Am. Coll. Cardiol.,
February 26, 2008;
51(8):
793 - 801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Materazzo, P. Piotti, C. Mantovani, R. Miceli, and F. Villani
Atrial fibrillation after non-cardiac surgery: P-wave characteristics and Holter monitoring in risk assessment
Eur. J. Cardiothorac. Surg.,
May 1, 2007;
31(5):
812 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wiesbauer, O. Schlager, H. Domanovits, B. Wildner, G. Maurer, M. Muellner, H. Blessberger, and M. Schillinger
Perioperative {beta}-Blockers for Preventing Surgery-Related Mortality and Morbidity: A Systematic Review and Meta-Analysis
Anesth. Analg.,
January 1, 2007;
104(1):
27 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Burgess, M. J. Kilborn, and A. C. Keech
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis
Eur. Heart J.,
December 1, 2006;
27(23):
2846 - 2857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
651 - 745.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
e149 - e246.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation,
August 15, 2006;
114(7):
e257 - e354.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud
Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest,
August 1, 2005;
128(2_suppl):
39S - 47S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kailasam, C. A. Palin, and C. W. Hogue Jr
Atrial Fibrillation After Cardiac Surgery: An Evidence-Based Approach to Prevention
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 2005;
9(1):
77 - 85.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. DiDomenico and M. G. Massad
Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery
Ann. Thorac. Surg.,
February 1, 2005;
79(2):
728 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Engoren
Is a Charge a Cost If Nobody Pays It?
Chest,
September 1, 2004;
126(3):
662 - 664.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kerstein, A. Soodan, M. Qamar, M. Majid, E. Lichstein, G. Hollander, and J. Shani
Giving IV and Oral Amiodarone Perioperatively for the Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Surgery: The GAP Study
Chest,
September 1, 2004;
126(3):
716 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest,
September 1, 2004;
126(3_suppl):
429S - 456S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Nielsen, T. Bahnson, R. D. Davis, and S. M. Palmer
Atrial Fibrillation After Pulmonary Transplant
Chest,
August 1, 2004;
126(2):
496 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Cummings, I. Gill, R. Akhrass, M. Dery, L. A. Biblo, and K. J. Quan
Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans
J. Am. Coll. Cardiol.,
March 17, 2004;
43(6):
994 - 1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Debrunner, B. Naegeli, M. Genoni, M. Turina, and O. Bertel
Prevention of atrial fibrillation after cardiac valvular surgery by epicardial, biatrial synchronous pacing
Eur. J. Cardiothorac. Surg.,
January 1, 2004;
25(1):
16 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-K. Au, S.-W. Chiu, M.-P. Sun, L.-C. Cheung, and L.-C. Cheng
Biatrial Pacing to Prevent Atrial Fibrillation After Coronary Artery Bypass
Asian Cardiovasc Thorac Ann,
September 1, 2003;
11(3):
222 - 225.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J.F. M. Bechtel, J. F. Christiansen, H.-H. Sievers, and C. Bartels
Low-energy cardioversion versus medical treatment for the termination of atrial fibrillation after CABG
Ann. Thorac. Surg.,
April 1, 2003;
75(4):
1185 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A D Taylor, J G Groen, S L Thorn, C T Lewis, and A J Marshall
New insights into onset mechanisms of atrial fibrillation and flutter after coronary artery bypass graft surgery
Heart,
December 1, 2002;
88(5):
499 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Forlani, R. De Paulis, S. de Notaris, P. Nardi, F. Tomai, I. Proietti, A. S. Ghini, and L. Chiariello
Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting
Ann. Thorac. Surg.,
September 1, 2002;
74(3):
720 - 726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Crystal, S. J. Connolly, K. Sleik, T. J. Ginger, and S. Yusuf
Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery: A Meta-Analysis
Circulation,
July 2, 2002;
106(1):
75 - 80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Wurdeman, A. N. Mooss, S. M. Mohiuddin, and T. L. Lenz
Amiodarone vs Sotalol as Prophylaxis Against Atrial Fibrillation/Flutter After Heart Surgery* : A Meta-Analysis
Chest,
April 1, 2002;
121(4):
1203 - 1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Maisel, J. D. Rawn, and W. G. Stevenson
Atrial Fibrillation after Cardiac Surgery
Ann Intern Med,
December 18, 2001;
135(12):
1061 - 1073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur. Heart J.,
October 2, 2001;
22(20):
1852 - 1923.
[PDF]
|
 |
|

|
 |

|
 |
 
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
1266 - 1266.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fan, K. L. Lee, C. S.W. Chiu, J. W.T. Lee, G.-W. He, D. Cheung, M. P. Sun, and C.-P. Lau
Effects of Biatrial Pacing in Prevention of Postoperative Atrial Fibrillation After Coronary Artery Bypass Surgery
Circulation,
August 15, 2000;
102(7):
755 - 760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Greenberg, N. M. Katz, S. Iuliano, B. J. Tempesta, and A. J. Solomon
Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery
J. Am. Coll. Cardiol.,
May 1, 2000;
35(6):
1416 - 1422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Daubert and P. Mabo
Atrial pacing for the prevention of postoperative atrial fibrillation: how and where to pace?
J. Am. Coll. Cardiol.,
May 1, 2000;
35(6):
1423 - 1427.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Burkart and A. B. Curtis
Reviews: Atrial Fibrillation: Current and Future Strategies for Management
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 2000;
5(3):
151 - 160.
[PDF]
|
 |
|
|